- News & Analysis
- Home
- Global Corporate Venturing
- Global University Venturing
- Latest News
- Publications
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- Video
- Subscribe
- Newsletters
- Events
Page 55
Daily Deal Round Up: April 30, 2021
Driverless vehicle developer EasyMile closed a $66.4m round featuring Alstom and Continental while UCB and LivaNova-backed EEG technology developer Ceribell secured $53m.
Apr 30, 2021Modern Meadow manages $130m series C round
The Evonik and Continental Grain Company-backed bio-based materials producer has appointed a new CEO alongside its latest funding round.
Apr 30, 2021Wasabi warms up with $112m series C
Fidelity led a series C round for NTT Docomo-backed cloud storage services provider Wasabi that increased its valuation to $700m.
Apr 30, 2021OpenClassrooms stays course for $80m series C
Salesforce Ventures has chipped into the online learning platform’s latest round, bringing its overall funding to about $150m.
Apr 30, 2021Yiauto accelerates to $70m series C
Susquehanna International Group's SIG China subsidiary led a round for the online car dealership that included several existing backers.
Apr 30, 2021Kaia Health stretches to $75m series C
The pain management platform developer has now raised at least $125m altogether, after pulling in series C funding from investors including Optum.
Apr 30, 2021OpenSpace snaps up $55m in series C round
JLL and New World Development have participated in a series C round for the construction imaging technology provider, which has increased its total funding to over $88m.
Apr 30, 2021MessageBird's series C mushrooms to $1bn
Bonnier was among the investors that added $800m to the marketing technology provider's latest round, with $600m funding its purchase of SparkPost.
Apr 29, 2021Caresyntax collects $100m of series C funding
Intel, Optum, Relyens and Rezayat Group all invested in the surgery software provider, which is also backed by Mitsubishi, Barco Healthcare, Norgine and Takeda.
Apr 29, 2021Arch Oncology arranges $105m series C
The cancer therapy developer has now collected more than $240m altogether, having completed a series C round that included Roche Venture Fund.
Apr 29, 2021
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.